KaloBios Pharma (KBIO) Announces Filing of 10-Q, 10-K for 2015 Sep 2, 2016 07:31AM
KaloBios Files Outstanding 10-Q and 10-K for 2015 Sep 2, 2016 07:30AM
KaloBios Pharma (KBIOQ) Affirms Martin Shkreli Exit of Stake in Company Aug 29, 2016 09:28AM
KaloBios Announces Martin Shkreli’s Sale of His Stake in the Company Aug 29, 2016 09:25AM
KaloBios (KBIOQ) Enters Deal to Buyback Former CEO Martin Shkreli's Shares Jul 7, 2016 07:05AM


Jul 7, 2016 07:00AM KaloBios Signs Definitive Agreement with Martin Shkreli Regarding Ownership of Shares
Jul 1, 2016 07:03AM KaloBios (KBIOQ) Completes Chapter 11 Bankruptcy; Acquires Benznidazole Development Rights
Jul 1, 2016 07:00AM KaloBios Emerges from Chapter 11 Bankruptcy
May 25, 2016 03:00AM KaloBios CEO to Present at the International Society for Neglected Tropical Diseases Conference
Apr 11, 2016 08:01AM KaloBios Pharmaceuticals (KBIOQ) Announces New Pricing Model
Apr 11, 2016 08:00AM KaloBios Announces New Product Pricing Model
Feb 3, 2016 12:19PM Ex-drug executive Shkreli has $40 million trading loss: U.S.